Targeting the Molecular and Immunologic Features of LeiomyosarcomaBrandon Cope, Elise F. Nassif|Cancers|2023Cited by 26
ETCTN 10563: A phase I study of peposertib and liposomal doxorubicin for advanced or metastatic leiomyosarcoma and other sarcomas.Candace L. Haddox, Suzanne George, Elise F. Nassif et al.|Journal of Clinical Oncology|2025Cited by 1